• Bluebird Regulators Map Out Approval Plan For Gene Therapy

    May 19, 2015, 00:00 AM by Michael Croft
    Xconomy | One of gene therapy's major unanswered questions is just what it'll take to convince U.S. regulators to approve one of these treatments.
    Full story
  • Latest Report - Enterprise ICT investment plans-ICT budget and staffing trends in Pharmaceuticals

    May 18, 2015, 00:00 AM by Michael Croft
    SAN FRANCISCO, CA, UNITED STATES - May 18, 2015 - Product Synopsis
     
    This report presents the findings from a survey of 102 pharmaceutical companies regarding their Information and Communications Technology (ICT) budgets and staff allocation
    Full story
  • Can We Identify Every Kind of Cell in the Body

    May 18, 2015, 00:00 AM by Michael Croft
    MIT Technology Review | With new tools to isolate individual cells and profile their genetic signatures, researchers are undertaking a microscopic quest to find out what we're really made of.
    Full story
  • Kapa Biosystems Launches New RNA Prep Kit to Maximize Sequencing Efficiency

    May 18, 2015, 00:00 AM by Michael Croft
    WILMINGON, MA, UNITED STATES - May 18, 2015 - Kapa Biosystems, Inc., today launched a new RNA library preparation product for next-generation sequencing (NGS) workflows that enables users to generate a more complete view of the transcriptome by detecting more low-abundance and unique transcripts
    Full story
  • Unlocking the Value of Smart Data & Analytics at Smart Data Summit Dubai Next Week

    May 18, 2015, 00:00 AM by Michael Croft
    DUBAI, UNITED ARAB EMIRATES - May 18, 2015 - The 2nd Annual Smart Data Summit will take place next week on 25-26 May at Sofitel Dubai The Palm Resort and Spa, Dubai, UAE
    Full story
  • Michael J. Fox Foundation Brings Parkinson's Data to tranSMART

    May 15, 2015, 10:15 AM by Michael Croft
    Bio-IT World | The Michael J. Fox Foundation, dedicated to driving basic research in Parkinson's disease, received a special Judges' Prize at this year's Bio-IT World Best Practices Awards for its work implementing the tranSMART platform for data sharing and analysis, including innovative programs like a patient registry and integration with studies of other neurodegenerative diseases.
    Full story
  • Oxford Nanopore Announces Auto Sample Prep, New Chips, Pay-As-You-Go Pricing

    May 14, 2015, 14:00 PM by Michael Croft
    Bio-IT World | Clive Brown’s Oxford Nanopore took over our Twitter feed on Thursday afternoon with news coming out of the London Calling event (#nanoporeconf). Many in attendance (and watching the Twitter feed) called the announcements “game-changing” and likened the atmosphere to Apple’s iPhone announcement in 2007. 
    Full story
  • Mayo Clinic Embarks on Population-Scale Pharmacogenomics Study

    May 14, 2015, 10:00 AM by Michael Croft
    Bio-IT World News Brief | Mayo Clinic in Rochester, Minn., has announced plans to sequence genes from 10,000 patients for genetic variants that could affect their responses to a variety of medications, as part of a study that will track the long-term health outcomes of patients who undergo pharmacogenetic testing.
    Full story
  • Allen Institute Debuts Neuron Periodic Table

    May 14, 2015, 00:00 AM by Michael Croft
    Xconomy | With the Allen Cell Types Database, the Allen Institute for Brain Science aims to catalog and classify the types of neurons that fill the brain.
    Full story
  • Genentech Brain Trust Raises $217m For New Startup To Fight Alzheimers And Parkinsons

    May 14, 2015, 00:00 AM by Michael Croft
    Forbes | Three former top researchers at Genentech, the legendary biotech that is now part of Roche Holding, have raised $217 million in venture capital to start a new company, Denali Therapeutics, focused on treating and curing neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's.
    Full story
  • Citizen Science in the Unexplored Terrain of the Brain

    May 13, 2015, 10:25 AM by Michael Croft
    Bio-IT World | To understand how neural circuits give rise to complex mental phenomena, neuroscientists need detailed maps of brain cells in their natural environment. With an online game called EyeWire, one group of researchers is enlisting thousands of ordinary people to do what the best artificial intelligence cannot: turn huge numbers of electron microscope images of the retina into accurate, three-dimensional models of neurons as they appear in living tissue.
    Full story
  • Cleversafe Joins iRODS Consortium

    May 12, 2015, 14:00 PM by Michael Croft
    Bio-IT World | Cleversafe, a private cloud platform, announced today that it has joined the iRODS Consortium, a membership-based foundation organized to sustain the integrated Rule-Oriented Data System (iRODS) as free open source data management software. 
    Full story
  • Genedata Screener Now Supports Streamlined Collaboration among Pharmas and CROs

    May 12, 2015, 00:00 AM by Michael Croft
    BASEL, SWITZERLAND - May 12, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the Genedata Screener® platform supports data- and result-sharing with Contract Research Organizations (CROs)
    Full story
  • Jennifer Doudna a Pioneer Who Helped Simplify Genome Editing

    May 11, 2015, 00:00 AM by Michael Croft
    New York Times | The biochemist at the University of California, Berkeley, helped make a monumental discovery: a relatively simple way to alter any organism's DNA. But she is stuck in a patent fight over it.
    Full story
  • Looking Forward to the Clinical Genome Conference

    May 7, 2015, 11:00 AM by Michael Croft
    Bio-IT World CHI’s Clinical Genome Conference (TCGC) always offers a packed schedule of talks at the cutting edge of medical genomics. With a program once again pushing the envelope of where genomics and medicine will take us in the coming year, we aren’t expecting much down time over the three event days, though we always work in at least one trip out of San Francisco’s Japantown for Burmese tea leaf salad. Here’s what else we are looking forward to on the TCGC menu.
    Full story
  • PacBio, RainDance to Co-Develop De Novo Whole Genome Assembly Product

    May 6, 2015, 09:00 AM by Michael Croft
    Bio-IT World News Briefs | Pacific Biosciences and RainDance Technologies yesterday announced a co-development and co-marketing agreement to commercialize novel solutions for de novo whole genome assembly.
    Full story
  • Apple Pursues DNA Data

    May 6, 2015, 00:00 AM by Michael Croft
    MIT Technology Review | Apple is collaborating with U.S. researchers to launch apps that would offer some iPhone owners the chance to get their DNA tested, many of them for the first time, according to people familiar with the plans. The apps are based on ResearchKit.
    Full story
  • IBM Announces Watson Genomic Analytics; Collaborations with 14 Cancer Centers

    May 5, 2015, 16:00 PM by Michael Croft
    Bio-IT World | IBM Watson made a series of announcements today at World of Watson, a symposium IBM is hosting in New York. In opening remarks, IBM CEO Ginni Rometty highlighted Watson Genomic Analytics; introduced collaborations with 14 leading cancer centers to use the solution to scale precision oncology; and announced a partnership with Epic to integrate Watson into EHR systems.
    Full story
  • iSpecimen® Technology Consolidates the Procurement Process for Human Biospecimens

    May 5, 2015, 00:00 AM by Michael Croft
    LEXINGTON, MA, UNITED STATES - May 5, 2015 - iSpecimen, a trusted source of customized human biospecimen collections, today released its latest technology that connects biomedical researchers to high quality, annotated human biospecimens that would otherwise be discarded by hospitals and labs after clinical testing is complete
    Full story
  • Phil Bourne: Open Data Evangelist on NIH Data Plan

    May 4, 2015, 16:00 PM by Michael Croft
    Bio-IT World | Before we get ahead of ourselves, Philip Bourne, Associate Director of Data Science at NIH, emphasized that in the 6D framework of patient-centered health, we are still mired in “deception”—step two—and haven’t yet reached disruption. Democratization is still far on the horizon.
    Full story